Skip to main content

OptiNose, Inc.

OPTNDelisted May 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001494650

OptiNose, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 21, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $65.6M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by OptiNose, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for OptiNose, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for OptiNose, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Helton Sandra LDirector–May 21, 20250
Fletcher R JohnDirector–May 21, 20250
Groenhuysen Wilhelmus CMDirector–May 21, 20250
Marino Michael F IIIChief Legal Officer & Corp Sec0May 21, 20250
Mahmoud Ramy AChief Executive Officer0IndirectMay 21, 20250
Heyman Tomas J.Director–May 21, 20250
Kohler TerryChief Financial Officer0May 21, 20250
Bednarski EricDirector–May 21, 20250
Dempsey KyleDirector–May 21, 20250
Spence Paul Jr.Chief Commercial Officer0May 21, 20250
Krick Anthony JChief Accounting Officer140,758Jul 18, 20240
Owen Catherine E.Director–Jun 7, 20240
Avista Capital Partners II, L.P.10% Owner48,370IndirectMay 16, 20230
Avista Capital Partners (Offshore) II, L.P.10% Owner48,370IndirectMay 16, 20230
Avista Capital Partners (Offshore) II-A, LP10% Owner48,370IndirectMay 16, 20230
Avista Capital Partners II GP, LLC10% Owner48,370IndirectMay 16, 20230
Miller Peter KChief Executive Officer853,384Jan 17, 20230
Clavelli Victor MChief Commercial Officer199,955Dec 19, 20220
Janis MicheleActing Chief Financial Officer48,927Dec 19, 20220
Scodari Joseph CDirector–Jun 9, 20220
Goldan Keith A.Chief Financial Officer141,726Mar 17, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2024 (view filing)Sep 171 dayMahmoud Ramy AChief Executive OfficerSSale−4.88K$0.87−$4.25K−0.4%1.20M after
Sep 18, 2024 (view filing)Sep 171 dayMarino Michael F IIIChief Legal Officer & Corp SecSSale−3.23K$0.87−$2.81K−0.6%547.2K after
Dec 18, 2024 (view filing)4:35 PM ETDec 171 dayMahmoud Ramy AChief Executive OfficerSSale−4.61K$0.44−$2.03K−0.4%1.20M after
Dec 18, 2024 (view filing)4:37 PM ETDec 171 dayMarino Michael F IIIChief Legal Officer & Corp SecSSale−3.05K$0.44−$1.34K−0.6%544.2K after
Mar 4, 2025 (view filing)Mar 4Same dayMahmoud Ramy AChief Executive OfficerSSale−6.38K$5.29−$33.7K−4.8%126.9K after
Mar 4, 2025 (view filing)Mar 4Same dayMarino Michael F IIIChief Legal Officer & Corp SecSSale−2.15K$5.29−$11.3K−3.7%55.3K after
Mar 4, 2025 (view filing)Mar 4Same daySpence Paul Jr.Chief Commercial OfficerSSale−1.22K$5.29−$6.47K−3.6%32.6K after
Mar 19, 2025 (view filing)Mar 181 dayMahmoud Ramy AChief Executive OfficerSSale−368$5.61−$2.06K−0.3%126.6K after
Mar 19, 2025 (view filing)Mar 181 dayMarino Michael F IIIChief Legal Officer & Corp SecSSale−246$5.61−$1.38K−0.4%55.0K after